TEDESCHI, SARA
 Distribuzione geografica
Continente #
AS - Asia 5.742
NA - Nord America 5.007
EU - Europa 4.385
SA - Sud America 380
AF - Africa 265
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.801
Nazione #
US - Stati Uniti d'America 4.933
CN - Cina 1.647
SG - Singapore 1.602
VN - Vietnam 1.209
IT - Italia 1.101
DE - Germania 731
GB - Regno Unito 565
NL - Olanda 491
SE - Svezia 415
HK - Hong Kong 327
KR - Corea 274
BR - Brasile 262
IN - India 239
FR - Francia 227
RU - Federazione Russa 181
IE - Irlanda 137
FI - Finlandia 110
JP - Giappone 110
CI - Costa d'Avorio 89
BG - Bulgaria 75
ZA - Sudafrica 58
CH - Svizzera 54
AR - Argentina 50
ES - Italia 48
AT - Austria 44
UA - Ucraina 43
JO - Giordania 42
ID - Indonesia 38
CA - Canada 37
BE - Belgio 36
EE - Estonia 36
TG - Togo 35
BD - Bangladesh 33
PH - Filippine 31
IQ - Iraq 28
NG - Nigeria 27
MX - Messico 24
TR - Turchia 24
TH - Thailandia 23
PK - Pakistan 20
PL - Polonia 17
TW - Taiwan 17
AU - Australia 16
EC - Ecuador 15
SC - Seychelles 15
CL - Cile 12
CO - Colombia 12
RO - Romania 12
SA - Arabia Saudita 12
LT - Lituania 10
MY - Malesia 10
UZ - Uzbekistan 10
PE - Perù 8
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
GR - Grecia 6
HR - Croazia 6
IR - Iran 6
PT - Portogallo 6
UY - Uruguay 6
VE - Venezuela 6
EG - Egitto 5
KE - Kenya 5
KZ - Kazakistan 5
AL - Albania 4
AZ - Azerbaigian 4
CY - Cipro 4
DZ - Algeria 4
LY - Libia 4
NP - Nepal 4
PY - Paraguay 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
LV - Lettonia 3
MA - Marocco 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BY - Bielorussia 2
BZ - Belize 2
IL - Israele 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
AO - Angola 1
BS - Bahamas 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
Totale 15.781
Città #
Singapore 1.140
Ashburn 640
Hefei 558
Southend 456
Fairfield 435
Frankfurt am Main 379
Eygelshoven 338
Chandler 321
Hong Kong 310
Ho Chi Minh City 303
San Jose 271
Hanoi 254
Seoul 250
Bologna 231
Santa Clara 206
Wilmington 200
Woodbridge 198
Ann Arbor 196
Beijing 169
Houston 166
Seattle 166
Cambridge 147
Dublin 136
Princeton 129
New York 118
Boardman 109
Dong Ket 101
Milan 100
Lauterbourg 95
Tokyo 90
Abidjan 89
Helsinki 83
Los Angeles 77
Sofia 71
Dallas 65
Bengaluru 54
Rome 53
Nanjing 44
Westminster 43
Chicago 42
Da Nang 42
Haiphong 42
Amman 41
Council Bluffs 41
Berlin 39
Bern 39
Buffalo 38
Padova 37
Munich 36
Redondo Beach 36
Saint Petersburg 36
Lomé 35
São Paulo 35
Amsterdam 31
Jinan 31
Turin 31
Brussels 30
Vienna 30
San Diego 29
Bremen 28
Redmond 28
Falls Church 27
Guangzhou 27
Nuremberg 27
Shanghai 26
Jakarta 25
London 25
Modena 24
Abeokuta 21
Shenyang 20
Changsha 19
Orem 19
Florence 18
Redwood City 18
Hebei 17
Nanchang 17
Parma 17
Washington 17
Hải Dương 16
Lappeenranta 16
Tongling 16
Dearborn 15
Des Moines 15
Naples 15
Thái Nguyên 15
Zhengzhou 15
Denver 14
Hangzhou 14
Rio de Janeiro 14
San Francisco 14
Toronto 14
Yubileyny 14
Biên Hòa 13
Can Tho 13
Baghdad 12
Brooklyn 12
Falkenstein 12
Tampa 12
Verona 12
Warsaw 12
Totale 10.237
Nome #
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 928
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 314
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 252
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 240
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 227
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 225
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 219
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 217
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 214
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 213
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 213
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 209
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 197
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 197
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 196
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 195
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 190
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 189
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 187
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 182
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 182
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 179
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 179
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 178
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 173
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 172
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 172
Multidisciplinary treatment protocol for ischiatic, sacral, trochanteric or other pressure injuries in people with spinal cord injury: a retrospective cohort study 171
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 170
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 169
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 166
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 163
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 162
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections 161
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 160
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections? 159
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 159
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections 158
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 158
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 158
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 158
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 157
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 157
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 157
Bone and Joint Infections: The Role of Imaging in Tailoring Diagnosis to Improve Patients' Care 156
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 151
Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series 147
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 147
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 144
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study 143
Combined Orthoplastic Approach in Fracture-Related Infections of the Distal Tibia 141
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 141
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 141
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 141
In the search for appropriateness in the cure of vaginitis: a model of anti-fungal stewardship? 138
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 138
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients. 133
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 132
Effective Containment of a COVID-19 Subregional Outbreak in Italy through Strict Quarantine and Rearrangement of Local Health Care Services 131
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 130
Multiple Flaps for Trochanteric Pressure Sore Reconstruction: A Case Series 129
Opportunistic infections in end stage liver disease 125
A local outbreak as mirror-like scenario for COVID-19 worldwide progression. Clinical presentation to the Emergency Department during one of the first sub-regional outbreak in Italy A lesson to learn 124
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 124
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 124
Epidemiology of Fungal Periprosthetic Joint Infection: A Systematic Review of the Literature 123
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 123
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 122
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 121
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring 120
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 120
GPT-based chatbot tools are still unreliable in the management of prosthetic joint infections 119
Individualizing duration of antibiotic therapy in community-acquired pneumonia 119
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 116
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort 114
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 114
"MRI, culture of swab specimen and two stage surgery in spinal cord injury patients with pressure sores" 112
An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic 110
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 110
Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter study 109
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 108
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 105
Synchronous Periprosthetic Joint Infections: A Scoping Review of the Literature 99
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 99
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group 97
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study 93
The Need for Multidisciplinarity in Modern Medicine: An Insight into Orthopaedic Infections 92
Obesity Is One of the Strongest Risk Factor for Respiratory Failure and Death in COVID-19 Patients: A Retrospective Multicentric Cohort Study 92
null 91
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis 91
null 90
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 88
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" 83
The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus 81
Osteomyelitis of the pelvic bones in patients with spinal cord injury: Is magnetic resonance useful for preoperative diagnosis? 80
null 77
null 76
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 75
Totale 15.688
Categoria #
all - tutte 42.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 77 55 256
2021/20221.393 61 56 65 144 121 77 80 100 77 157 257 198
2022/20231.603 123 177 87 219 147 118 60 113 294 68 112 85
2023/2024897 70 90 54 105 76 194 63 58 33 72 36 46
2024/20252.709 112 247 214 214 313 149 196 93 58 244 263 606
2025/20266.860 718 857 649 567 639 664 947 183 1.178 458 0 0
Totale 16.143